Aarti Pharmalabs Limited (NSE:AARTIPHARM) — Market Cap & Net Worth
Market Cap & Net Worth: Aarti Pharmalabs Limited (AARTIPHARM)
Aarti Pharmalabs Limited (NSE:AARTIPHARM) has a market capitalization of $645.54 Million (Rs59.69 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #11134 globally and #550 in its home market, demonstrating a 5.83% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aarti Pharmalabs Limited's stock price Rs658.50 by its total outstanding shares 90647294 (90.65 Million). Review AARTIPHARM total debt and obligations to assess the company's total debt and financial obligations.
Aarti Pharmalabs Limited Market Cap History: 2023 to 2026
Aarti Pharmalabs Limited's market capitalization history from 2023 to 2026. Data shows growth from $491.81 Million to $645.54 Million (27.86% CAGR).
Index Memberships
Aarti Pharmalabs Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$149.83 Billion | 0.43% | #83 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.24 Trillion | 0.02% | #433 of 750 |
Weight: Aarti Pharmalabs Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aarti Pharmalabs Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aarti Pharmalabs Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Aarti Pharmalabs Limited's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.27x
Aarti Pharmalabs Limited's market cap is 0.27 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $491.81 Million | $19.45 Billion | $1.93 Billion | 0.03x | 0.25x |
| 2024 | $672.74 Million | $18.16 Billion | $2.17 Billion | 0.04x | 0.31x |
| 2025 | $737.59 Million | $21.15 Billion | $2.72 Billion | 0.03x | 0.27x |
Competitor Companies of AARTIPHARM by Market Capitalization
Companies near Aarti Pharmalabs Limited in the global market cap rankings as of June 19, 2026.
Key companies related to Aarti Pharmalabs Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #555 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #601 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Aarti Pharmalabs Limited Historical Marketcap From 2023 to 2026
Between 2023 and today, Aarti Pharmalabs Limited's market cap moved from $491.81 Million to $ 645.54 Million, with a yearly change of 27.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs645.54 Million | -12.48% |
| 2025 | Rs737.59 Million | +9.64% |
| 2024 | Rs672.74 Million | +36.79% |
| 2023 | Rs491.81 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Aarti Pharmalabs Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $645.54 Million USD |
| MoneyControl | $645.54 Million USD |
| MarketWatch | $645.54 Million USD |
| marketcap.company | $645.54 Million USD |
| Reuters | $645.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aarti Pharmalabs Limited
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous sys… Read more